KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity (2019 - 2025)

Historic Return on Equity for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.03%.

  • Castle Biosciences' Return on Equity fell 400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.04% for FY2024, which is 1900.0% up from last year.
  • Castle Biosciences' Return on Equity amounted to 0.03% in Q3 2025, which was down 400.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Equity registered a high of 0.04% during Q4 2024, and its lowest value of 0.23% during Q2 2023.
  • Moreover, its 5-year median value for Return on Equity was 0.08% (2021), whereas its average is 0.09%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -1200bps in 2021, then soared by 2300bps in 2024.
  • Over the past 5 years, Castle Biosciences' Return on Equity (Quarter) stood at 0.08% in 2021, then plummeted by -118bps to 0.17% in 2022, then grew by 11bps to 0.15% in 2023, then surged by 128bps to 0.04% in 2024, then crashed by -165bps to 0.03% in 2025.
  • Its Return on Equity stands at 0.03% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.